Telesis Bio, Inc. (TBIO)
USD 0.43
(50.88%)
USD 0.43
(50.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 70.41 Million USD | -13.46% |
| 2022 | 81.36 Million USD | -30.02% |
| 2021 | 116.25 Million USD | 332.78% |
| 2020 | 26.86 Million USD | -30.7% |
| 2019 | 38.76 Million USD | -86.52% |
| 2018 | 287.65 Million USD | 44.88% |
| 2017 | 198.54 Million USD | -3.41% |
| 2016 | 205.56 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 52.72 Million USD | -16.74% |
| 2024 Q1 | 63.33 Million USD | -10.06% |
| 2023 Q1 | 89.16 Million USD | 9.59% |
| 2023 Q4 | 70.41 Million USD | -32.96% |
| 2023 Q2 | 114.52 Million USD | 28.45% |
| 2023 FY | 70.41 Million USD | -13.46% |
| 2023 Q3 | 105.02 Million USD | -8.29% |
| 2022 Q3 | 88.14 Million USD | -9.4% |
| 2022 Q4 | 81.36 Million USD | -7.69% |
| 2022 FY | 81.36 Million USD | -30.02% |
| 2022 Q1 | 111.13 Million USD | -4.41% |
| 2022 Q2 | 97.28 Million USD | -12.46% |
| 2021 Q3 | 124.49 Million USD | -8.74% |
| 2021 Q1 | 31.31 Million USD | 16.58% |
| 2021 FY | 116.25 Million USD | 332.78% |
| 2021 Q4 | 116.25 Million USD | -6.62% |
| 2021 Q2 | 136.41 Million USD | 335.59% |
| 2020 Q2 | 454.27 Million USD | 48.83% |
| 2020 Q4 | 26.86 Million USD | -97.04% |
| 2020 Q3 | 908.62 Million USD | 100.02% |
| 2020 Q1 | 305.24 Million USD | -9.21% |
| 2020 FY | 26.86 Million USD | -30.7% |
| 2019 Q3 | 349.51 Million USD | 15.52% |
| 2019 Q1 | 277.73 Million USD | -3.45% |
| 2019 FY | 38.76 Million USD | -86.52% |
| 2019 Q4 | 336.2 Million USD | -3.81% |
| 2019 Q2 | 302.54 Million USD | 8.93% |
| 2018 Q1 | 182.83 Million USD | -7.91% |
| 2018 FY | 287.65 Million USD | 44.88% |
| 2018 Q4 | 287.65 Million USD | -5.56% |
| 2018 Q3 | 304.58 Million USD | 83.12% |
| 2018 Q2 | 166.33 Million USD | -9.03% |
| 2017 FY | 198.54 Million USD | -3.41% |
| 2017 Q4 | 198.54 Million USD | 0.0% |
| 2016 FY | 205.56 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -124.482% |
| BrainsWay Ltd. | 62.97 Million USD | -11.813% |
| Cerus Corporation | 197.74 Million USD | 64.394% |
| Envoy Medical, Inc. | 7.64 Million USD | -821.61% |
| electroCore, Inc. | 16.38 Million USD | -329.676% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -815.38% |
| IceCure Medical Ltd | 16.41 Million USD | -329.074% |
| Inogen, Inc. | 326.19 Million USD | 78.414% |
| OrthoPediatrics Corp. | 449.58 Million USD | 84.339% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -158.199% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -324.7% |
| MaxCyte, Inc. | 268.27 Million USD | 73.754% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -769.56% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1838.674% |
| Orthofix Medical Inc. | 925.31 Million USD | 92.391% |
| PAVmed Inc | 33.11 Million USD | -112.6% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 50.917% |
| RxSight, Inc. | 182.55 Million USD | 61.429% |
| Sight Sciences, Inc. | 166.65 Million USD | 57.749% |
| SI-BONE, Inc. | 230.42 Million USD | 69.443% |
| TELA Bio, Inc. | 78.04 Million USD | 9.785% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 72.049% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -556.207% |
| Acutus Medical, Inc. | 53.96 Million USD | -30.487% |
| Talis Biomedical Corporation | 98.34 Million USD | 28.4% |
| Spectral AI, Inc. | 10.69 Million USD | -558.539% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 67.797% |
| CVRx, Inc. | 115.22 Million USD | 38.895% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -20.03% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2160.202% |
| Bioventus Inc. | 810.91 Million USD | 91.317% |
| Venus Concept Inc. | 93.65 Million USD | 24.818% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -173.707% |
| LivaNova PLC | 2.42 Billion USD | 97.102% |
| 908 Devices Inc. | 202.98 Million USD | 65.312% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 91.256% |
| Nemaura Medical Inc. | 14.56 Million USD | -383.485% |
| NeuroPace, Inc. | 107.65 Million USD | 34.593% |
| LENSAR, Inc. | 69.58 Million USD | -1.187% |
| Apyx Medical Corporation | 79.24 Million USD | 11.142% |
| Cutera, Inc. | 346.29 Million USD | 79.667% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -67.581% |
| BioSig Technologies, Inc. | 1.79 Million USD | -3816.073% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 73.983% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -65.048% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.138% |
| Axonics, Inc. | 719.92 Million USD | 90.22% |
| Outset Medical, Inc. | 313.8 Million USD | 77.562% |
| IRIDEX Corporation | 34.43 Million USD | -104.469% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 82.602% |
| IRadimed Corporation | 92.15 Million USD | 23.596% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1240.141% |
| INVO Bioscience, Inc. | 20.88 Million USD | -237.092% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 54.309% |
| Varex Imaging Corporation | 1.24 Billion USD | 94.365% |
| Quipt Home Medical Corp. | 247.4 Million USD | 71.541% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -656.294% |
| Pulmonx Corporation | 178.95 Million USD | 60.653% |
| Dynatronics Corporation | 25.94 Million USD | -171.432% |
| Modular Medical, Inc. | 13.8 Million USD | -409.966% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -556.39% |
| Semler Scientific, Inc. | 78.06 Million USD | 9.805% |
| InMode Ltd. | 863.28 Million USD | 91.844% |
| Bruker Corporation | 4.24 Billion USD | 98.343% |
| Cytosorbents Corporation | 53.26 Million USD | -32.201% |
| DexCom, Inc. | 6.26 Billion USD | 98.876% |
| Align Technology, Inc. | 6.08 Billion USD | 98.843% |
| Viveve Medical, Inc. | 25.91 Million USD | -171.721% |
| ZimVie Inc. | 1.2 Billion USD | 94.158% |
| Movano Inc. | 9.42 Million USD | -647.384% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 85.852% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1838.674% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -20.03% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 92.609% |
| Profound Medical Corp. | 43.68 Million USD | -61.174% |
| Insulet Corporation | 2.58 Billion USD | 97.28% |
| enVVeno Medical Corporation | 48.63 Million USD | -44.774% |
| Surmodics, Inc. | 185.73 Million USD | 62.09% |
| iCAD, Inc. | 41.41 Million USD | -70.001% |
| Nuwellis, Inc. | 9.77 Million USD | -620.686% |
| Biotricity, Inc. | 5.94 Million USD | -1084.847% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 83.744% |
| Aethlon Medical, Inc. | 8.24 Million USD | -753.883% |
| InspireMD, Inc. | 47.64 Million USD | -47.789% |
| PAVmed Inc. | 33.11 Million USD | -112.6% |
| BIOLASE, Inc. | 35.1 Million USD | -100.595% |
| Beyond Air, Inc. | 56.96 Million USD | -23.613% |
| FONAR Corporation | 214.24 Million USD | 67.135% |
| AxoGen, Inc. | 196.82 Million USD | 64.227% |
| Vivani Medical, Inc. | 45.79 Million USD | -53.746% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 74.982% |
| Inari Medical, Inc. | 674.23 Million USD | 89.557% |
| UFP Technologies, Inc. | 404.13 Million USD | 82.577% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -200.92% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -640.926% |
| Tenon Medical, Inc. | 6.34 Million USD | -1009.708% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -648.496% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 32.067% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.476% |
| Sintx Technologies, Inc. | 15.36 Million USD | -358.256% |
| NanoVibronix, Inc. | 6.67 Million USD | -955.004% |
| Quanterix Corporation | 425.01 Million USD | 83.433% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -656.294% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -31.053% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 95.967% |
| TransMedics Group, Inc. | 706.04 Million USD | 90.027% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -11.424% |
| NeuroMetrix, Inc. | 21.42 Million USD | -228.648% |
| Hyperfine, Inc. | 94.19 Million USD | 25.253% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 73.79% |
| Biomerica, Inc. | 9.25 Million USD | -660.871% |
| Bone Biologics Corporation | 3.73 Million USD | -1783.774% |
| AVITA Medical, Inc. | 144.33 Million USD | 51.219% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1346.247% |
| Silk Road Medical, Inc | 265.3 Million USD | 73.461% |